/ /

CLINICAL

Reviewing anterior segment ARVO 2017 postersSo much basic science research is presented at this meeting, and most of it will be years before it makes its way to clinical trials. Let’s concentrate on research that might be of use to us in the exam room very soon.
VMA associated with poor outcomes in anti-VEGF-treated patientsThe presence of vitreomacular adhesion (VMA) is associated with poorer, short-term anatomic, and functional outcomes in eyes with diabetic macular edema (DME) receiving anti-VEGF therapy, according to Márcio B. Nehemy, MD, PhD.
Why DAILIES® AquaComfort Plus® Is My #1 Contact Lens Choice For TeensFor many eye care professionals (ECPs), helping patients see, look and feel their best means being able to offer their patients daily disposable contact lenses. The DAILIES® Choice Program is an opportunity to provide patients with a convenient alternative to weekly and monthly replacement lenses by reducing the price barrier for new wearers with up to $200 in savings on a year’s supply of DAILIES® lenses.
Dry eye checklist may help ODs treat patients more efficiently
Dry eye checklist may help ODs treat patients more efficientlyScott Schachter, OD, discusses dry eye and how incorporating a dry eye checklist may help improve patient treatment.
IOL selection important in patients with retinal diseaseWhen dealing with patients with retinal disease, macular disease, or a meaningful risk of retinal detachment, certain types of IOLs should be avoided due to potential complications.
How to manage vision changes over time post-LASIK
How to manage vision changes over time post-LASIKHow often have you heard a post-LASIK patient say his surgery “isn’t working anymore” or it has “expired?” While the corneal tissue that was ablated is gone forever, eyes can change over time, and laser vision correction does not stop time.
Translatable animal model needed if glaucoma research is achievableAnimal models are vital to glaucoma research. The problem is that no single animal model fully recapitulates the natural history of human glaucoma. A model that mimicked the progression and time line of human glaucoma would do little to speed drug discovery.
Growing number of devices set to transform glaucoma treatmentMinimally invasive glaucoma surgery (MIGS) is the latest development in the treatment of glaucoma. With two MIGS devices already approved in the United States, there are a variety of novel devices that have the potential to transform the treatment of glaucoma.
Shire utilizing biotech approach to meet unmet ophthalmic needsShire, which built its experience in biotech agents, is taking a biotech approach to meeting unmet needs in both the anterior and poster segments of ophthalmology.
Artificial intelligence will bring ‘reality’ to glaucoma diagnosisRobert Chang, MD, outlines how artificial intelligence might work in glaucoma.